4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008115
CHIEF FINANCIAL OFFICER sold 36,372 shares at $22.25 ($809,277)
- CHIEF FINANCIAL OFFICER acquired 36,372 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-12 | Option exercise 10b5-1 | +36,372 | $11.97 | $435,373 | 59,330 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-12 | Sale 10b5-1 | −36,372 | $22.25 | $809,277 | 22,958 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2025-03-12 | Option exercise · Share Option 10b5-1 | −36,372 | 28,288 | D | ||
| Open-market sales · 36,372 sh · avg $22.25 · $809,277 | |||||||
Loading xslF345X05/form4-03142025_080318.xml…